Australia markets closed

NVO Dec 2024 195.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
52.420.00 (0.00%)
At close: 10:18AM EDT
Full screen
Loading interactive chart…
  • Yahoo Finance Video

    Novo Nordisk stock closes lower, analyst warns about Wegovy sales

    Shares of Novo Nordisk (NVO) slipped on Friday following a note from JPMorgan's Richard Vosser. Vosser warned that the pharmaceutical giant's third quarter results could show a slowing in sales of the company's blockbuster weight-loss drug Wegovy. Market Domination Anchors Julie Hyman and Josh Lipton discuss the call in the video above. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Stephanie Mikulich.

  • Zacks

    PFE vs. NVO: Which Stock Is the Better Value Option?

    PFE vs. NVO: Which Stock Is the Better Value Option?

  • Investor's Business Daily

    Novo Nordisk Slips On Analyst Warning Of Weaker Wegovy Sales

    Novo Nordisk stock fell after a JPMorgan analyst said sales of its blockbuster weight-loss drug may be weaker-than-expected.